Barbara Ellers-Lenz

Title: Barbara Ellers-Lenz: Innovator in Cochlear Tinnitus Treatment

Introduction

Barbara Ellers-Lenz is a notable inventor based in Moerfelden-Walldorf, Germany. She has made significant contributions to the field of medical treatments, particularly in addressing cochlear tinnitus. With a total of 2 patents, her work has the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

Her latest patents include innovative solutions for treating cochlear tinnitus. The first patent, titled "1-amino-cyclohexane derivatives for the treatment of cochlear tinnitus," focuses on administering an effective amount of a 1-amino-alkylcyclohexane derivative to individuals afflicted with this condition. The second patent, "Titration package for neramexane and its use in the treatment of an inner ear disorder," outlines a titration scheme that allows for the quick attainment of an effective dose while minimizing side effects. This titration package is designed to provide the derivative in at least two different dosages, making it a versatile option for treating various diseases, including tinnitus.

Career Highlights

Barbara Ellers-Lenz is currently associated with Merz Pharma GmbH & Co. KGaA, where she continues to develop her innovative ideas. Her work is characterized by a commitment to advancing medical treatments and improving patient outcomes.

Collaborations

Throughout her career, Barbara has collaborated with esteemed colleagues such as Hagen Kruger and Michael Althaus. These partnerships have contributed to the success of her projects and the advancement of her research.

Conclusion

Barbara Ellers-Lenz is a pioneering inventor whose work in cochlear tinnitus treatment showcases her dedication to medical innovation. Her patents reflect a significant advancement in the field, promising better treatment options for those affected by this condition.